# PPMI Tau PET Imaging

> **NCT04906590** · PHASE2 · COMPLETED · sponsor: **Michael J. Fox Foundation for Parkinson's Research** · enrollment: 23 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** [18F] PI-2620

## Key facts

- **NCT ID:** NCT04906590
- **Lead sponsor:** Michael J. Fox Foundation for Parkinson's Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-30
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-02-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04906590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04906590, "PPMI Tau PET Imaging". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04906590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*